Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2025-12-26 @ 3:29 AM
Study NCT ID:
NCT00313820
Status:
COMPLETED
Last Update Posted:
2021-02-09
First Post:
2006-04-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Efficacy Of Pregabalin In Subjects With Post-Stroke Central Neuropathic Pain
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
A0081063
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None